5% Imiquimod 크림을 사용한 피부종양의 치료경험 = 5% Imiquimod Cream for the Treatment of Cutaneous Tumor5% Imiquimod 크림을 사용한 피부종양의 치료경험

다국어 초록 (Multilingual Abstract)

Background: Imiquimod is an immune response modifier that shows antiproliferative and antiviral characteristics through synthesis of multiple cytokines. Although it was originally approved by the FDA for the treatment of genital warts, it has also been successfully used to treat various dermatological conditions. Objective: The aim of this study was to report our treatment experience of cutaneous tumors with 5% imiquimod cream, and to contemplate the effectiveness and safety of its use for purpose. Methods: We reviewed 21 patients with biopsy-proven cutaneous tumors who were treated with 5% imiquimod cream. Data was collected through medical records, clinical photographs, and biopsy specimens. Results: The patients had various cutaneous tumors including actinic keratosis, Bowen`s disease, Bowenoid papulosis, keratoacanthoma, superficial basal cell carcinoma and invasive squamous cell carcinoma. Among 17 patients who were initially treated with 5% imiquimod cream, 13 patients (76.5%) achieved clinical complete re-mission, and histologic cure was also confirmed in four. No recurrence was observed during the follow up period in these 13 patients. While applying 5% imiquimod cream, all the patients experienced local side effects but it was mild and generally well-tolerated. Conclusion: Topical immunotherapy of cutaneous tumors with 5% imiquimod cream has potential as a patient-friendly, well-tolerated therapy that can achieve cosmetically and functionally pleasing treatment outcomes. (Korean J Dermatol 2007;45(10):989∼995)

참고문헌 (Reference)

1 "Two cases of squamous cell carcinoma treated with topical imiquimod 5%" 18 : 93-95, 2004

2 "Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod" 95 : 1138-1149, 2003

3 "Topically applied imiquimod inhibits vascular tumor growth in vivo" 121 : 1205-1209, 2003

4 "Topical treatment with imiquimod may induce regression of facial keratoacanthoma" 13 : 80-82, 2003

5 "Topical treatment with 5% imiquimod for solitary keratoacanthoma" 42 : 1321-1324, 2004

6 "Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod cream" 41 : 1002-1007, 1999

7 "The Skin Cancer Foundation [online]" 2006

8 "Successful treatment of invasive squamous cell carcinoma using topical imiquimod. Arch Dermatol" 404-406, 2004

9 "Successful topical immunotherapy of Bowenoid papulosis with imiquimod" 145 : 1022-1036, 2001

10 "Role of imiquimod in skin cancer treatment" 5 : 453-458, 2004

11 "Oral Bowenoid papulosis in an HIV-positive male" 101 : 328-332, 2006

12 "Nonmelanoma skin cancer" 3 : 193-203, 2002

13 "Imiquimod: modes of action" 149 : S5-S8, 2003

14 "Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma" 31 : 371-374, 2005

15 "Imiquimod, a topical immune response, modifier, induces migrtion of Langerhans cells" 114 : 135-141, 2000

16 "Imiquimod in basal cell carcinoma: how does it work?" 149 : 57-58, 2003

17 "Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial" 54 : 1025-1032, 2006

18 "Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma" 54 : 1025-1032, 2006

19 "Imiquimod 5% cream in the treatment of Bowen's disease" 44 : 462-470, 2001

20 "Imiquimod 5% cream for the treatment of superficial basal cell carcinoma" 47 : 390-398, 2002

21 "Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle" 149 : 59-61, 2003

22 "Current and potential uses of imiquimod" 98 : 913-919, 2005

23 "Bowenoid papulosis successfully treated with imiquimod" 17 : 348-372, 2003

24 "A review of imiquimod 5% cream for the treatment of various dermatological conditions" 28 : S1-S3, 2003

25 "A randomized, double-blind, vehicle-controlled study to assess imiquimod 5% cream for the treatment of actinic keratosis" 138 : 1498-1502, 2002

26 "A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily" 74 : 1482-1486, 1996

27 "A case of basal cell carcinoma of the nose successfully treated with 5% imiquimod cream" 42 : 646-649, 2004

28 "A case of actinic keratosis treated with topical imiquimod" 42 : 1201-1204, 2004

29 "5% imiquimod cream in the treatment of Bowen's disease" 45 : 338-344, 2007

30 "5% cream treatment for superficial basal cell carcinoma" 44 : 807-813, 2001